Lebrikizumab (IL13) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-338
Artikelname: Lebrikizumab (IL13) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-338
Hersteller Artikelnummer: 10-338
Alternativnummer: PRS-10-338-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / IL13 [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: MILR1444A,PRO301444
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.